Zhiqiang Shu
Stock Analyst at Berenberg
(0.11)
# 4,138
Out of 4,820 analysts
8
Total ratings
14.29%
Success rate
-21.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Zhiqiang Shu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Initiates: Buy | $26 | $19.72 | +31.85% | 1 | Mar 23, 2023 | |
| KRON Kronos Bio | Initiates: Buy | $12 | $0.89 | +1,248.31% | 1 | Sep 14, 2022 | |
| BPMC Blueprint Medicines | Initiates: Buy | $90 | $88.51 | +1.68% | 1 | Sep 14, 2022 | |
| STRO Sutro Biopharma | Initiates: Buy | $30 | $0.90 | +3,222.63% | 1 | Nov 17, 2021 | |
| SNSE Sensei Biotherapeutics | Downgrades: Hold | $12 | $0.40 | +2,877.67% | 1 | Jul 1, 2021 | |
| NRIX Nurix Therapeutics | Initiates: Buy | n/a | $11.47 | - | 1 | Apr 14, 2021 | |
| STTK Shattuck Labs | Initiates: Buy | $47 | $0.80 | +5,745.04% | 1 | Apr 14, 2021 | |
| RPTX Repare Therapeutics | Initiates: Buy | $51 | $1.36 | +3,650.00% | 1 | Mar 1, 2021 |
IDEAYA Biosciences
Mar 23, 2023
Initiates: Buy
Price Target: $26
Current: $19.72
Upside: +31.85%
Kronos Bio
Sep 14, 2022
Initiates: Buy
Price Target: $12
Current: $0.89
Upside: +1,248.31%
Blueprint Medicines
Sep 14, 2022
Initiates: Buy
Price Target: $90
Current: $88.51
Upside: +1.68%
Sutro Biopharma
Nov 17, 2021
Initiates: Buy
Price Target: $30
Current: $0.90
Upside: +3,222.63%
Sensei Biotherapeutics
Jul 1, 2021
Downgrades: Hold
Price Target: $12
Current: $0.40
Upside: +2,877.67%
Nurix Therapeutics
Apr 14, 2021
Initiates: Buy
Price Target: n/a
Current: $11.47
Upside: -
Shattuck Labs
Apr 14, 2021
Initiates: Buy
Price Target: $47
Current: $0.80
Upside: +5,745.04%
Repare Therapeutics
Mar 1, 2021
Initiates: Buy
Price Target: $51
Current: $1.36
Upside: +3,650.00%